Published in Vaccine Weekly, January 17th, 2007
The company reported that its stockholders approved the following proposals:
1. To re-elect the five current directors of the company: Roger I. Gale, chairman and chief executive officer; John J. DiPietro; Paul E. Freiman; Julius R. Krevans, MD; and Maxim A. Soulimov, who will hold...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly